Zuccolotto et al. studied the molecular interaction of PSMA CAR-T cells in the preclinical setting and revealed that the CAR-T cells effectively eradicated disseminated tumor cells after in-vivo transfer in tumor-bearing mice, which supported the use of this modality for clinical purposes [56]. This evidence concerns the gene FOLH1 and neoplasm.